KALV

Kalvista Pharm

• TipRanks·5d ago

  KalVista’s Sebetralstat Extension Study Completion Sets Up Key Catalyst for KALV Investors

• TipRanks·05/30 02:09

  Top Executive’s Surprise Stock Move Shakes Up KalVista Investors

• PUBT·05/29 20:06

  KalVista Chief Development Officer Christopher Yea sells 33,800 shares for $905,224.84

• TipRanks·05/28 11:33

  KalVista presents new data on injectable on-demand treatment in children

• Benzinga·05/28 11:12

  KalVista Pharmaceuticals Announces New Data That Highlight Burden Of Injectable On-Demand Treatment In Children Aged 2–11 With Hereditary Angioedema

• PUBT·05/28 11:01

  KalVista highlights US claims analysis showing heavy ER use, off-label injectables in children with hereditary angioedema

• TipRanks·05/16 06:00

  Merger Agreement With Chiesi Puts Strategic Handcuffs on KalVista, Raising Execution and Liquidity Risks

• TipRanks·05/15 11:41

  Analysts Offer Insights on Healthcare Companies: KalVista Pharmaceuticals (KALV), PTC Therapeutics (PTCT) and Veru (VERU)

• Reuters·05/08 11:18

  KALVISTA PHARMACEUTICALS INC <KALV.O>: STIFEL CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $27 FROM $42

• Reuters·05/08 07:12

  U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson

• TipRanks·05/07 20:46

  KalVista downgraded to Hold from Buy at Stifel

• Seeking Alpha·05/05 14:05

  Most and least shorted small-to-mid-cap stocks

• Seeking Alpha·05/04 13:50

  Most and least shorted healthcare stocks with up to $2B market cap in May

• Seeking Alpha·05/03 15:15

  Key deals this week: Organon, ARC Resources, Nebius, Eli Lilly and more

• Benzinga·05/01 18:35

  Deal Dispatch: Sirius XM Mulls Purchase Of iHeartMedia, Uber Buys FlyTaxi, Wren Kitchens Bankruptcy